This is the latest episode of the free DDW narrated podcast, “Immunotherapy, avelumab and protecting the immunocompromised”, which covers three articles written for Volume 23, Issue 3 – Summer 2022 of DDW. They are called “Mice with humanised immune systems advance cell-based immunotherapy”, “The avelumab story and what it means for urothelial carcinoma”, and “Immunocompromised are ‘forgotten’ when it comes to viral protection”.
In the first article, you will hear from Courtney Ferrebee, PhD, Field Applications Scientist, Taconic Biosciences.
In the second article, Lu Rahman speaks to Dr Stuart Hill, Medical Director for Merck, about the development of the avelumab and what this means for the treatment of bladder cancer.
In the third article, Dr. Jeffery Stein, CEO of Cidara and an expert in viral diseases, talks about the drug-Fc conjugate (DFCs), a new class of immunotherapeutic antivirals.